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distributed in the intracellular fluid, and 1% is distrib-
uted in the extracellular fluid. Circulating Mg exists in
3 forms: a protein-bound fraction (25% bound to albu-
min and 8% bound to globulins), a chelated fraction
(12%), and the physiologically active ionized fraction
(IMg; 55%).1 Total serum magnesium concentration
M agnesium (Mg) is an important regulator of multi-ple cardiovascular processes, including myocar-
dial conduction, myocardial contractility, transmem-
brane calcium flux, potassium transport, vascular
smooth muscle tone, coronary vascular reactivity, and
nitric oxide synthesis.1-4 Ninety-nine percent of Mg is
Objectives: We sought to (1) determine reference values for whole blood ion-
ized magnesium concentrations in newborns, children, and young adults and
(2) evaluate the frequency and clinical implications of ionized hypomagne-
semia in patients undergoing surgery for congenital heart disease.
Method: We prospectively measured ionized magnesium concentrations in
299 subjects (113 control subjects and 186 patients undergoing surgery for
congenital heart disease). Subjects were categorized by age. In the surgical
group blood samples were obtained before bypass, during bypass (cooling
and rewarming), after bypass, and during admission to the intensive care
unit. Ionized hypomagnesemia was defined as ionized magnesium level 2
standard deviations below the mean of control subjects in the same age
group. Patients were analyzed, controlling for cardiopulmonary bypass time.
Results: In the control group ionized magnesium concentrations differed by
age. Neonates and adults showed lower ionized magnesium concentrations
compared with those of other age groups. Infants exhibited the highest ion-
ized magnesium concentration. In the surgical group patients older than 1
month showed a higher proportion of ionized hypomagnesemia compared
with that found in neonates at baseline (P < .001), after bypass (P = .03), and
at admission to the intensive care unit (P = .02). Controlling for cardiopul-
monary bypass time, patients older than 1 month who were hypomagne-
semic during bypass showed longer intubation time (P = .001) and longer
intensive care stay (P = .01) and tended to have a higher pediatric severity of
illness score on intensive care admission (P = .14) compared with patients
without ionized hypomagnesemia.
Conclusions: There are age-related differences in normal ionized magne-
sium concentrations. Ionized hypomagnesemia is a common and clinical-
ly relevant occurrence among patients older than 1 month of age under-
going surgery for congenital heart disease. (J Thorac Cardiovasc Surg
2000;119:891-8)
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(MgT), which includes the protein-bound, chelated,
and ionized fractions, was the first and most easily
measured form of Mg and is the clinical measurement
routinely used for assessing circulating Mg. Total
serum hypomagnesemia has been associated with
hypokalemia, hypocalcemia, cardiac arrhythmias,
ischemic heart disease, myocardial injury, low cardiac
output syndrome, hypertension, cardiomyopathy, sud-
den death, and muscular weakness.1,4,5 Total serum
hypomagnesemia has been reported in up to 94% of
adult patients during cardiopulmonary bypass (CPB),6
but the level is altered by factors such as pH, serum
protein concentrations, and illness severity.1 Further-
more, it has been recently demonstrated that patients
with ionized hypomagnesemia may have normal levels
of MgT.3,7
Accurate measurement of IMg has only recently been
available in clinical practice. Pediatric patients during
CPB exhibit alterations in IMg. These alterations differ
depending on both patient weight and the use of cardio-
plegic solution.8 In addition, preoperative medication to
treat congestive heart failure and hemodilution on CPB
may also contribute to ionized hypomagnesemia.
Because of previous technical limitations in the mea-
surement of IMg and lack of normative data, there is lit-
tle information regarding the frequency and clinical
implications of ionized hypomagnesemia in patients
undergoing CPB during operations for congenital car-
diac disease. We hypothesized that ionized hypomag-
nesemia may be a common and clinically relevant
problem in patients undergoing CPB during operations
for congenital cardiac disease. To test this hypothesis,
we measured IMg concentrations in 113 control
patients to obtain reference values and in 186 patients
undergoing CPB during operations for congenital heart
disease.
Patients and methods
The protocol was approved by the Institutional Review
Boards at Children’s Hospital in Boston and Mount Auburn
Hospital in Cambridge, Massachusetts. A total of 1303 blood
samples were obtained from 299 subjects (113 control
patients and 186 patients undergoing CPB during surgery for
congenital cardiac disease). Patients were selected between
April 1996 and April 1998 by using convenience sampling.
We obtained written informed consent from parents or from
the subjects older than 17 years of age.
Control patients. The control group included 15 healthy
term neonates, 85 children undergoing noncardiac minor
elective operative procedures, and 13 healthy adults. The 15
normal neonates had a venous blood sample drawn at 48
hours of life. Children had a venous blood sample drawn dur-
ing the preoperative evaluation. Excluded from the control
group were patients with any medical history of a disorder
known to alter Mg metabolism, including malnutrition, alco-
holism, nephropathies, asthma, sepsis, diabetes, pancreatitis,
cardiac disease, endocrine disorder, malabsorption syn-
dromes, and transfusion therapy.1 Also excluded from the
control group were patients receiving medications known to
interfere with Mg metabolism (eg, diuretics, digoxin, amino-
glycosides, carbenicillin, cisplatinum, methotrexate, cyclo-
sporine [INN: ciclosporin], ethanol, terbutaline, pentamidine,
and citrate).1 None of the control subjects, including mothers
of neonates, received Mg supplementation.
Surgical group. Study patients included 186 nonconsecu-
tive subjects (77 female and 109 male subjects) undergoing
operations for congenital cardiac disease. Depending on the
surgeon’s preference, patients received one of the following
cardioplegic solutions: Plegisol (Abbott Laboratories, North
Chicago, Ill) or a custom-made cardioplegic solution (Table
I). For every four parts of custom-made cardioplegic solution,
one part of pump blood was added. The composition of the
bypass circuit and perfusion protocols were according to
established institutional practices. The circuits were primed
with Plasma-Lyte solution (Baxter, Deerfield, Ill) and whole
blood if necessary to achieve a patient hematocrit level of
greater than 20%. All patients undergoing deep hypothermic
CPB with either circulatory arrest or low flow were adminis-
tered furosemide 0.25 mg/kg and methylprednisolone 30
mg/kg as a single bolus within the first minute of CPB. All
patients received mannitol 0.5 mg/kg at the time of aortic
crossclamp removal.
After anesthesia was achieved, a baseline arterial blood
sample was taken before CPB; additional arterial blood sam-
ples were drawn during both cooling and rewarming on CPB,
immediately after separating from CPB, and during admis-
sion to the cardiac intensive care unit (CICU). Arterial blood
(1 mL) was collected into a heparinized blood gas syringe (25
USP of dry heparin per milliliter) and was immediately ana-
lyzed on the Ultra C analyzer (Nova Biomedical, Waltham,
Mass) for IMg, blood gases, hematocrit level, electrolytes,
Ca++, lactate, and glucose. Quality controls were performed
on the analyzer before laboratory determinations.
Because of the range of diagnoses, ages, and surgical pro-
cedures, patients were compared at the time of admission to
the CICU by using the pediatric severity of illness (PRISM
III) score.9 This was calculated by recording blood pressure,
heart rate, temperature, arterial blood gases, glucose, elec-
trolytes, creatinine, blood urea nitrogen, white blood cells,
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Table I. Composition of cardioplegic solutions
Plegisol solution Custom-made solution
Mg2+ 32 mEq/L 3 mEq/L
Ca2+ 2.4 mEq/L —
K+ 16 mEq/L 30 mEq/L
Na+ 110 mEq/L 140 mEq/L 
CL– 160 mEq/L 98 mEq/L
Gluconate — 23 mEq/L
prothrombin time, partial thromboplastin time, and platelets
on CICU admission. Arrhythmias were recorded during anes-
thesia and after CICU admission by means of continuous
electrocardiographic monitoring. In addition, medications,
duration of mechanical ventilation, and CICU length of stay
were recorded.
Ionized hypomagnesemia was defined as an IMg concen-
tration more than 2 SDs below the mean IMg concentration
of control subjects in the same age group. During CPB, ion-
ized hypomagnesemia was defined as the average of all mea-
surements during this period.
Statistical analysis. Because IMg concentrations were not
normally distributed, a log transformation was used when
defining ionized hypomagnesemia. Age-related differences
were determined by using 1-way analysis of variance with a
Bonferroni correction for multiple comparisons. Differences
in proportions were analyzed by using the Fisher exact test.
Medians were compared by using the Wilcoxon rank-sum
test. Controlling for CPB time, the PRISM III score, duration
of mechanical ventilation, and CICU stay were analyzed by
means of multiple linear regression methods after performing
a log transformation. Mortality was analyzed by logistic
regression. All multivariable analyses were done for neonates
and nonneonates separately. Analyses were performed by
using the Stata statistical package (Stata Corporation, College
Station, Tex).
Results
Control group. The IMg concentration varied with
age and was significantly lower in neonates (Fig 1).
Means ± SD for IMg are as follows: 1 month or less,
0.47 ± 0.05 mmol/L; greater than 1 month and less than
1 year, 0.71 ± 0.09 mmol/L; 1 to 4 years, 0.65 ± 0.07
mmol/L; 5 to 11 years, 0.62 ± 0.05 mmol/L; 12 to 19
years, 0.64 ± 0.06 mmol/L; and 20 or more years, 0.53
± 0.03 mmol/L. Because there were no statistically sig-
nificant differences among patients 1 to 19 years of
age, these patients were analyzed as one group. There-
fore 4 age groups provided our reference values from
neonate to adulthood (Fig 2).
Surgical group. One hundred eighty-six patients
were studied: 47 neonates (median age, 6 days; range
1-27 days); 48 infants (median age, 0.37 years; range,
0.09-0.96 years); 83 children (median age, 3.7 years;
range, 1.1-19.3 years); and 8 adults 20 years of age or
older (median age, 30 years; range, 20.7-39.8 years).
The median age of all patients studied was 11.4 months
(range, 1 day to 39.8 years). Types of surgical proce-
dures are shown in Table II, and patient demographics
and CPB details are shown in Table III. There were no
statistically significant differences in frequency of ion-
ized hypomagnesemia at baseline on the basis of sex (P
= .9). The overall mortality for the patients studied was
9% (17/186). Because of patient selection bias (non-
consecutive patients), this mortality does not represent
our actual institutional mortality for cardiac surgery
over this period, which was 2.8%.
Preoperative IMg. Compared with our control
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Fig 1. Scatter plot of IMg versus age for the control group. Vertical lines indicate age categories. Scatter of IMg
levels between newborns and infants is shown in the inset graph.
group, preoperative ionized hypomagnesemia was a
common finding in our patients with congenital car-
diac defects who were older than 1 month of age,
occurring in 41% of patients. The percentage of
neonates with preoperative ionized hypomagnesemia
was significantly lower than that of older patients
(10% vs 41%, P < .001; Fig 3).
Preoperative medications were being taken by 79
(42%) of 186 patients, most commonly digoxin (n = 47),
furosemide (n = 57), or captopril (n = 27). In neonates
there was no association between preoperative use of
furosemide and frequency of ionized hypomagnesemia
during CPB. In contrast, a greater proportion of patients
older than 1 month taking furosemide before surgery had
ionized hypomagnesemia during CPB than patients tak-
ing other or no medications (55% vs 34%, P = .04).
Intraoperative IMg. The changes in IMg levels dur-
ing the measured time points are shown in Table IV.
There was a decrease in IMg levels after the onset of
CPB in neonates and infants. However, by the end of
bypass, IMg had returned to the preoperative level.
Patients who received the custom-made cardioplegic
solution exhibited a higher incidence of ionized hypo-
magnesemia during (48% vs 27%, P = .01) and after
CPB (39% vs 17%, P = .003) compared with patients
who received Plegisol solution. Nevertheless, there
were no statistically significant differences in hemody-
namic variables, inotropic support, PRISM III score,
duration of mechanical ventilation, CICU stay, and
mortality between patients who received custom-made
cardioplegic solution and Plegisol solution.
CICU outcome. The differences in PRISM III score,
duration of mechanical ventilation and CICU stay, and
incidence of postoperative arrhythmias in patients with
and without ionized hypomagnesemia are shown in
Table V. Thirty-three (18%) of 186 patients had
arrhythmias (ventricular, n = 9; atrial, n = 24) during
the postoperative period. The incidence of arrhythmia
was not associated with ionized hypomagnesemia dur-
ing CPB (Table V).
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Fig 2. Reference values (± 2 SDs of the log transformation) for whole blood ionized Mg concentrations by age
group.
Table II. Surgical procedures
Surgical procedure No.
ASD/VSD 53
Right ventricular outflow tract repair 26
Valvuloplasty 10
Arterial switch operation 13
Norwood operation 16
Bidirectional Glenn anastomosis 13
Modified Fontan procedure 13
Atrioventricular canal repair 8
Left ventricular outflow tract repair 4
Cardiac transplantation 4
Coarctation of the aorta and VSD 4
Total anomalous pulmonary venous connection 2
Others 20
Total 186
ASD, Atrial septal defect; VSD, ventricular septal defect.
Because neonates had longer median CPB time com-
pared with patients older than 1 month (123 vs 87 min-
utes, P < .0001), they were analyzed separately. In the
multivariable analysis controlling for CPB time among
patients older than 1 month, the duration of mechanical
ventilation and CICU stay were longer in those who
were hypomagnesemic at baseline, during CPB, and
after CPB (Table VI). There was a tendency to have a
higher PRISM III score in patients who were hypo-
magnesemic at baseline and during CPB. In contrast to
patients older than 1 month, neonates with hypomag-
nesemia did not have a significantly higher PRISM III
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Fig 3. The prevalence of hypomagnesemia in neonates and patients older than 1 month during the perioperative
period.
Table III. Age, weight, sex, and CPB characteristics by age group
Total ≤1 mo 1 mo–1 y 1-19 y ≥20 y
Number 186 47 48 83 8
Age 11.4 mo (27 d–3.8 y) 6 d (4-10 d) 4.4 mo (2.3-7.7 mo) 3.7 y (2.3-9.9 y) 30.3 y (22.5–37.5 y)
Weight (kg) 7.3 (3.8-16) 3.2 (2.7-3.6) 5.4 (4.4-6.7) 14 (11-32.7) 62.5 (53-66.9)
Sex (M/F) 109/77 25/2 28/20 51/32 5/3
Prior medical therapy, n (%) 79 (42.5) 20 (42.5) 28 (58.3) 27 (32.5) 4 (50)
CPB duration (min) 101 (68-139) 123 (105-147) 98 (73-145) 80 (55-120) 102 (72-160)
Crossclamp time (min) 52 (33-73) 70 (46-79) 52 (34-80) 44 (25-63) 63 (50-107)
Circulatory arrest
Patients, n (%) 65 (34.9) 41 (87.2) 20 (41.7) 3 (3.6%) 1 (12.5)
Duration (min) 29 (14-43) 30 (16-49) 24 (9-38) 29 (16-42) 32 (32-32)
Data are expressed as median (25th-75th percentile) where applicable. CPB, Cardiopulmonary bypass.
Table IV. IMg levels across the perioperative period by age group
Total ≤1 mo 1 mo–1 y 1-19 y ≥20 y
Reference range (mmol/L) 0.61 (0.55-0.67) 0.46 (0.43-0.49) 0.72 (0.67-0.74) 0.63 (0.59-0.67) 0.53 (0.51-0.54)
Preoperative 0.54 (0.49-0.58) 0.48 (0.42-0.57) 0.56 (0.53-0.6) 0.54 (0.51-0.57) 0.54 (0.51-0.58)
Cooling CPB 0.43 (0.27-0.59) 0.33 (0.22-0.43) 0.30 (0.25-0.44) 0.58 (0.43-0.66) 0.58 (0.55-0.78)
Rewarming CPB 0.56 (0.46-0.74) 0.47 (0.38-0.53) 0.49 (0.43-0.64) 0.70 (0.53-1.2) 0.65 (0.55-0.93)
Post-CPB 0.56 (0.47-0.71) 0.48 (0.4-0.56) 0.51 (0.44-0.63) 0.65 (0.53-0.93) 0.56 (0.53-0.97)
CICU admission 0.60 (0.52-0.68) 0.58 (0.45-0.67) 0.59 (0.53-0.66) 0.62 (0.54-0.71) 0.59 (0.56-0.71)
Data are expressed as median (25th-75th percentile) as applicable. CPB, Cardiopulmonary bypass; CICU, cardiac intensive care unit.
score, increased duration of mechanical ventilation, or
prolonged CICU stay.
Ionized hypomagnesemia was associated with
hypokalemia (P = .04) and hypocalcemia (P = .01) dur-
ing CPB (Table V). After controlling for hypokalemia
and hypocalcemia, the relationship between hypomag-
nesemia and duration of mechanical ventilation and
CICU stay did not change.
Discussion
Control group. In contrast to previous reports,10,11
our study demonstrates age-related differences in
whole blood IMg concentrations. Newborns exhibited
the lowest IMg concentration, and infants exhibited the
highest IMg concentration within the whole group. The
IMg concentrations we measured in neonates are simi-
lar to values recently reported in healthy neonates at
birth and 24 hours of life,12 although the IMg values in
our study were measured at 48 hours of life. Our refer-
ence values for IMg may therefore not represent the
entire neonatal period, and further studies are neces-
sary to define the range of normal values in this age
group. This may explain the lack of association
between ionized hypomagnesemia and the measured
outcome variables in our surgical neonate group.
The causes of age-related differences in IMg concen-
trations were not assessed in our study. Renal losses
and changes in body fluid compartment and diet may
play a role in determining these differences. The ion-
ized fraction represents the physiologically active por-
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Table V. Difference in age, PRISM III score, duration of mechanical ventilation, CICU stay, arrhythmias,
hypokalemia, and hypocalcemia in patients with and without hypomagnesemia during CPB*
Yes No P value
No. 73 108 —
Age (y) 0.4 (33 d–1 y) 2.6 (20 d–9.2 y) .0002
PRISM III score 6 (2-8) 5 (2-7.5) .05
Duration of mechanical ventilation (h) 31.4 (16-71) 19 (9-50) .02
CICU stay (d) 2.9 (2-5) 2 (1-4) .02
Postoperative arrhythmia
Total, n (%) 9 (12.3) 23 (21.3) .16
Ventricular, n (%) 3 (4.1) 5 (4.6) 1
Atrial, n (%) 6 (8.2) 18 (16.7) .12
Hypo-Ca++ during CPB, n (%) 58 (79) 64 (59) .01
Hypo-K+ during CPB, n (%) 11 (15) 6 (6) .04
Mortality, n (%) 6 (8) 11 (10) .8
Data are expressed as median (25th-75th percentile) as applicable. Yes, Patients who were hypomagnesemic during CPB irrespective of age group; No, patients who
were not hypomagnesemic during CPB irrespective of age group; CICU, cardiac intensive care unit; CPB, cardiopulmonary bypass.
*Five patients did not have IMg measured during CPB.
Table VI. Relationships of outcome with ionized hypomagnesemia among patients older than 1 month, controlling
for CPB time*
Before CPB During CPB After CPB CICU admission
Regression Regression Regression Regression 
coefficient ± SE P value coefficient ± SE P value coefficient ± SE P value coefficient ± SE P value
Duration of mechanical 
ventilation (h)
Hypo-IMg 0.56 ± 0.24 .02 0.81 ± 0.23 .001 0.56 ± 0.25 .03 0.45 ± 0.28 .11
CBP time 0.011 ± 0.002 <.001 0.011 ± 0.002 <.001 0.010 ± 0.002 <.001 0.011 ± 0.002 <.001
CICU stay (d)
Hypo-IMg 0.41 ± 0.14 .003 0.36 ± 0.14 .01 0.29 ± 0.15 .05 0.18 ± 0.16 .3
CBP time 0.0067 ± .0012 <.001 0.0068 ± 0.0012 <.001 0.0061 ± .0013 <.001 0.0069 ± 0.0012 <.001
PRISM III score
Hypo-IMg 0.16 ± 0.12 .16 0.17 ± 0.11 .14 0.22 ± 0.12 .07 0.3 ± 0.13 .02
CPB time 0.0047 ± 0.001 <.001 0.0047 ± 0.001 <.001 0.0043 ± 0.0011 <.001 0.0046 ± 0.001 <.001
CICU, Cardiac intensive care unit; CPB, cardiopulmonary bypass; Hypo-IMg, ionized hypomagnesemia.
*The duration of mechanical ventilation, CICU stay, and PRISM III score were analyzed after performing a log transformation.
tion of the cation, and MgT is neither sensitive nor spe-
cific in predicting the ultrafilterable (ie, ionized plus
chelated) fraction of Mg.1 Age, serum albumin concen-
tration, pH, and serum salts may alter the distribution
of circulating Mg among the ionized, chelated, and
protein fraction. Although we did not measure serum
protein concentration, previous studies have shown no
significant differences in serum protein concentrations
among different age groups.13
Surgical group. The results of this study indicate
that ionized hypomagnesemia is a common and clini-
cally relevant problem in patients undergoing CPB dur-
ing operations for congenital cardiac disease. Ionized
hypomagnesemia may be present before the operation
and can also occur after hemodilution on CPB and
administration of cardioplegic solution.
Before surgery, 34% of our patients had ionized
hypomagnesemia. The cause of ionized hypomagne-
semia in this group of patients may be multifactorial.
Forty-two percent of our patients had taken at least one
cardiac medication (diuretics, vasodilators, or digoxin).
Digoxin impairs the Mg-dependent, cell membrane,
sodium-potassium, adenosine–triphosphatase pump,
inhibiting transcellular Mg transport and perhaps renal
tubular Mg reabsorption.14 Similarly, diuretics may
increase renal loss of Mg leading to hypomagne-
semia.14 In our study intraoperative ionized hypomag-
nesemia was more prevalent in those patients taking
furosemide before surgery.
Another factor that could contribute to ionized hypo-
magnesemia is suboptimal nutritional support and fail-
ure to thrive before surgery. Reduced oral feeding and
the administration of intravenous fluids supplying
inadequate Mg concentrations might be important fac-
tors favoring the development of ionized hypomagne-
semia in preoperative patients.
It has been reported that alterations in whole blood
IMg concentration occur during CPB in adults.8
However, because of lack of normative data in children,
the true prevalence and clinical relevance of ionized
hypomagnesemia during CPB has been unknown,
although our study indicates that ionized hypomagne-
semia is common during CPB.
The CPB circuit prime volume in neonates and
infants is large compared with the patient’s circulating
blood volume.15 In our study neonates exhibited the
highest frequency of ionized hypomagnesemia during
cooling, which could reflect hemodilution. Chelation
of IMg by acid-citrate–dextrose when donated blood is
used to prime the CPB circuit and could also contribute
to a fall in IMg.16
Although we did not demonstrate a statistically sig-
nificant difference in postoperative outcome between
the two cardioplegic solutions, ionized hypomagne-
semia was more common in patients who received the
custom-made cardioplegic solution than in patients
who received Plegisol solution. After CPB, normaliza-
tion of myocardial cell function is dependent on the
restoration of oxidative metabolism (repletion of cellu-
lar oxidative adenosine triphosphate stores). Mg is an
absolute requirement of oxidative phosphorylation, and
Mg deficiency may contribute to depletion of adeno-
sine triphosphate and subsequent poor myocardial per-
formance.17 Improved left ventricular systolic volume
index after intravenous Mg administration has been
demonstrated in adults after coronary artery bypass
grafting. Mg supplementation in pediatric patients
undergoing surgery for congenital cardiac disease dur-
ing the perioperative period could also enhance
myocardial recovery, but specific prospective studies
are necessary.
Contrary to other reports,1,6 ionized hypomagne-
semia during CPB was not associated with an increase
in frequency of ventricular arrhythmias in our patients
(8/181). Although supraventricular arrhythmias were
more common (24/181), once again the IMg level did
not appear to be a contributory factor.
Hypomagnesemia is often associated with other elec-
trolyte abnormalities, such as hypocalcemia and
hypokalemia,1,17-19 and in our study, patients with ion-
ized hypomagnesemia were more likely to have
hypocalcemia and hypokalemia during CPB and after
CPB than were those without ionized hypomagnesemia.
The dysfunction of cell membrane sodium-potassium-
adenosine-triphosphatase caused by ionized hypomag-
nesemia may allow efflux of potassium ions from the
cell, leading to intracellular hypokalemia.1 Moreover,
the kidney may be unable to adequately reabsorb potas-
sium during hypomagnesemic states, increasing the
renal loss of potassium.20 Diuretic therapy used in the
preoperative period of patients undergoing cardiac
surgery may be responsible for concomitant urinary Mg
and potassium losses.1,14 Despite the relationship
between ionized hypomagnesemia, hypocalcemia, and
hypokalemia, neither hypocalcemia nor hypokalemia
changed the effect of ionized hypomagnesemia on
CICU stay, duration of mechanical ventilation time, or
PRISM III score at CICU admission.
Although the duration of CPB may influence the out-
comes measured in our study, after controlling for the
duration of CPB by using linear regression methods,
patients in our study older than 1 month of age who
were hypomagnesemic during CPB had a longer peri-
od of mechanical ventilation, longer CICU stay, and a
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tendency for a higher PRISM III score on CICU admis-
sion.
Skeletal and respiratory muscle weakness has been
associated with hypo-MgT in critically ill neonates and
adults,1,21 and it is possible that respiratory muscle
weakness might be in part a contributing factor to the
increased duration of mechanical ventilation.
Limitation of the study
Because of the nonrandom method of patient selec-
tion, there was a selection bias toward patients with
more complicated congenital abnormalities with higher
mortality (study mortality of 9% of 186 patients),
which does not reflect our true institutional mortality
over that period (2.8% for 1332 patients undergoing
CPB). Selection of high-risk patients may have
increased the frequency of hypomagnesemia and its
correlation with adverse outcome. 
Conclusion
Our findings indicate that there are age-related differ-
ences in normal IMg concentration. Therefore ionized
hypomagnesemia should be defined on the basis of nor-
mative data for neonates, infants, children, and adults.
Perioperative ionized hypomagnesemia is a common
and possibly clinically relevant occurrence among
patients undergoing repair of congenital heart defects.
Patients older than 1 month who had ionized hypomag-
nesemia during CPB had a higher PRISM III score at
CICU admission, a longer period of mechanical ventila-
tion, and a longer CICU stay than did patients without
ionized hypomagnesemia. Our observations merit a ran-
domized trial of perioperative Mg administration.
R E F E R E N C E S
1. Salem M, Munoz R, Chernow B. Hypomagnesemia in critical ill-
ness: a common and clinically important problem. Crit Care Clin
1991;7:225-2.
2. Pearson PJ, Evora PRB, Seccombe JF, Schaff HV. Hypomag-
nesemia inhibits nitric oxide release from coronary endothelium:
protective role of magnesium infusion after cardiac operations.
Ann Thorac Surg 1998;65:967-72.
3. Maggioni A, Orzalesi M, Mimouni FB. Intravenous correction of
neonatal hypomagnesemia: effect on ionized magnesium. J Pediatr
1998;132:652-5.
4. Storm W, Zimmerman JJ. Magnesium deficiency and cardiogenic
shock after cardiopulmonary bypass. Ann Thorac Surg 1997;64:
572-7.
5. Caspi J, Rudis E, Bar I, Safadi T, Saute M. Effects of magnesium
on myocardial function after coronary artery bypass grafting.
Ann Thorac Surg 1995;59:942-7.
6. England MR, Gordon G, Salem M, Chernow B. Magnesium
administration and dysrrhythmias after cardiac surgery. JAMA
1992;268:2395-402.
7. Fiser RT, Torres A Jr, Butch AW, Valentine JL. Ionized magne-
sium concentrations in critically ill children. Crit Care Med 1998;
26:2048-52.
8. Fox ML, Burrows FA, Reid RW, Hickey PR, Laussen PC, Hansen
DD. The influence of cardiopulmonary bypass on ionized mag-
nesium in neonates, infants, and children undergoing repair of
congenital heart lesions. Anesth Analg 1997;84:497-500.
9. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated
pediatric risk of mortality score. Crit Care Med 1996;24:743-52.
10. Mays JE Jr, Keele DK. Serum magnesium levels in healthy chil-
dren and various disease states. Am J Dis Child 1961;102:623-54.
11. Anast CS. Serum magnesium levels in the newborn. Pediatrics
1964;33:969-74.
12. Cook LA, Mimouni FB. Whole blood ionized magnesium in the
healthy neonate. J Am Coll Nutr 1997;16:181-3.
13. Rothschild MA, Oratz M, Schreiber SS. Serum albumin.
Hepatology 1988;8:385-401.
14. Quamme GA, Dirks JH. Renal magnesium transport. Rev Physiol
Biochem Pharmacol 1983;97:69-110.
15. Kern FH, Morana NJ, Sears JJ, Hickey PR. Coagulation defects
in neonates during cardiopulmonary bypass. Ann Thorac Surg
1992;54:541-6.
16. Aglio LS, Stanford GG, Maddi R, Boyd III JL, Nussbaum S,
Chernow B. Hypomagnesemia is common following cardiac
surgery. J Cardiothorac Vasc Anesth 1991;5:201-8.
17. Leier CV, Dei Cas L, Metra M. Clinical relevance and manage-
ment of the major electrolyte abnormalities in congestive heart
failure: hyponatremia, hypokalemia, and hypomagnesemia. Am
Heart J 1994;128:564-74.
18. Aziz S, Haigh WG, Van Norman GA, Kenny RJ, Kenny MA.
Blood ionized magnesium concentrations during cardiopul-
monary bypass and their correlation with other circulating cations.
J Card Surg 1996;11:341-7.
19. Garty A, Alkalay A, Bernheim JL. Parathyroid hormone secretion
and responsiveness to parathyroid hormone in primary hypomag-
nesemia. Isr J Med Sci 1983;19:345-8.
20. Ryzen E. Magnesium homeostasis in critically ill patients.
Magnesium 1989;8:201-12.
21. Fiaccadori E, Del Canale S, Coffrini E, Melej R, Vitali P,
Guariglia A, et al. Muscle and serum magnesium in pulmonary
intensive care unit patients. Crit Care Med 1988;16:751-60.
898 Munoz et al The Journal of Thoracic and
Cardiovascular Surgery
May 2000
The Journal of Thoracic and
Cardiovascular Surgery
Volume 119, Number 5
Munoz et al 899
